Evidence map›Paper›PMID 40035808›Full record

ArticleProtoplasma2025

Seaweed-based PPO inhibitors as a new frontier in biological weed control for sorghum cultivation: from ocean to field.

Renuka Suresh, Ramanathan Karuppasamy

Abstract read
PubMed Publisher
In one paragraph

Article in Protoplasma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Renuka SureshDepartment of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India.
Ramanathan KaruppasamyDepartment of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India. kramanathan@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Weed management, particularly of broad-leaf species, poses a significant challenge in sorghum production, potentially causing up to 70.9% yield loss. Conventionally, herbicides are the site-specific weed inhibitors often used to suppress the growth of these weeds. Protoporphyrinogen oxidase (PPO) is an important target for developing novel herbicides with remarkable selectivity against these broad-leaved weeds. In particular, saflufenacil is a selective PPO herbicide that can provide temporary relief. However, their prolonged use could lead to various environmental constraints and the evolution of resistant weeds. Recently, bioherbicides are emerging as an alternative to commercial herbicides with safer environmental profiles and combat resistance. On that note, this study aimed to identify novel and safer bioherbicides derived from seaweeds to outright bans on the use of most synthetic herbicides and address herbicide resistance. High-end computational screening strategies including molecular docking, binding free energy, in-house developed ML-based VS, and herbicide-likeness were used to pinpoint the lead molecule against the wild and mutant (∆G210) type AtPPO. Finally, molecular dynamics simulations were employed to validate the binding kinetics of the hit compound. Indeed, the bromophenol derivative BL003, isolated from brown algae, emerged as the hit compound from our analysis. Remarkably, BL003 demonstrated superior binding affinity and stability compared to saflufenacil against both wild-type AtPPO and the mutant AtPPO

Indexed as

Enzyme InhibitorsProtoporphyrinogen OxidaseSeaweedSorghumWeed ControlHerbicidesMolecular Docking SimulationMolecular Dynamics SimulationPlant WeedsEnzyme InhibitorsHerbicidesProtoporphyrinogen OxidaseBroad-leavedHerbicide resistanceProtoporphyrinogen oxidaseSaflufenacilSeaweedWeeds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.